Hello all!
Please adjust accordingly.
Neville Harris
Administration Division
Neurocam International
neville.harris@neurocam.com
---------------------------- Original Message ----------------------------
Subject: FWD: Amendment to "Progress Report, April 2005."
From: "Bridget Fischer" <bridget.fischer@neurocam.com>
Date: Thu, April 28, 2005 4:23
To: "Neville Harris" <neville.harris@neurocam.com>
----------------------------------------
----------------------------------
Neville,
Please ensure that this amendment is forwarded to all members of middle
management.
Regards,
Bridget Fischer
Chief Executive Officer
Neurocam International
bridget.fischer@neurocam.com
---------------------------- Original Message ----------------------------
Subject: Amendment to "Progress Report, April 2005."
From: "Arthur Angus Verey" <arthur.verey@neurocam.com>
Date: Thu, April 28, 2005 0:44
To: "Bridget Fischer" <bridget.fischer@neurocam.com>, "Gertrude Zelle"
<gertrude.zelle@neurocam.com>, "Nancy Wake" <nancy.wake@neurocam.com>,
"Charles Hastings" <charles.hastings@neurocam.com>, "Lisa Andrews"
<lisa.andrews@neurocam.com>, "Sebastian Hoddle"
<sebastian.hoddle@neurocam.com>, "Marie Sachsen"
<marie.sachsen@neurocam.com>, "Xiao Yamato" <xiao.yamato@neurocam.com>,
"Nautonier" <nautonier.liaison@neurocam.com>, "Jack Sampson"
<jack.sampson@neurocam.com>, "Olga Chekhova" <olga.chekhova@neurocam.com>,
"Neville Harris" <neville.harris@neurocam.com>, "Otti Votavova"
<otti.votavova@neurocam.com>, "Samuel Stephenson"
<samuel.stephenson@neurocam.com>, "Madeline Khan"
<madeline.khan@neurocam.com>, "Elizabeth Van Lew"
<elizabeth.van.lew@neurocam.com>, "Reginald Rowland"
<reginald.rowland@neurocam.com>, "Herbert Finch"
<herbert.finch@neurocam.com>, "Peter Mason" <peter.mason@neurocam.com>,
"Peter H. Lee" <peter.lee@neurocam.com>, "Miles
Carrefour"<miles.carrefour@neurocam.com>, "Herbert Murphy"
<herbert.dyce.murphy@neurocam.com>
----------------------------------------
----------------------------------
Fellow Management,
Please note that recent developments have resulted in the inclusion of a
modicum of redundant and incorrect material in the recently disseminated
"Progress Report, April 2005".
I apologize for this occurrence, but assure you that the details included
were believed accurate at the time of printing.
In clarification - The concerns mentioned, within the report, in regards to
the unsuccessful laboratory trials of Compound H67T (pgs 23, 46, 61 & 72)
have now been satisfactorily resolved.
Whilst Compound H67T caused unforeseen complications in both the "Rhesus
macaque" and "Tonkean macaque" species, further experimentation utilizing
the species "Pan troglodytes verus" has been successful.
As the cerebral cortex of "Pan troglodytes verus" more closely resembles
that of "Homo Sapien" it is theorized that Compound H67T will be effective
in both instances. Based upon these findings, "Homo Sapien" experimentation
has been authorized and will commence in an expedient fashion.
I apologize once again for any inconvenience the inclusion of any inaccurate
material in the document "Progress Report, April 2005" may have caused, as
it now appears that our concerns were merely "clouds without water" and no
cause for alarm.
Regards,
Arthur Angus Verey
Head, Research and Development Division
Neurocam International
arthur.verey@neurocam.com
![[info]](http://l-stat.livejournal.com/img/community.gif?v=92.1){kind=small}
neurocam
relieved
contemplative
worried
bouncy
nervous